• VieMed Healthcare, Inc. (VMD) announced an innovative alliance with Commonwealth Primary Care ACO
  • Commonwealth’s clients will have access to VieMed’s clinically proven non-invasive home ventilation (NIVH)
  • A recent study showed that patients treated with NIVH had significantly better clinical outcomes than those who did not receive NIVH
  • ViaMed is a home medical equipment supplier that provides post-acute respiratory care services in the United States
  • Commonwealth operates as a federally chartered ACO serving the state of Arizona
  • VieMed Heathcare Inc. (VMD) is up 3.33 per cent, trading at C$13.05 per share at 10 am EST

Commonwealth Primary Care ACO and VieMed Healthcare (VMD) announce an innovative chronic respiratory care and sleep management alliance.

Commonwealth’s clients will have access to VieMed’s clinically proven Non-Invasive Ventilation at home (NIVH).

VieMed recently announced the results of an NIH study led by Dr. William Frazier, VieMed’s Chief Medical Officer. The study evaluated clinical outcomes in COPD patients with chronic respiratory failure (COPD-CRF) treated with NIVH compared to similar patients with COPD-CRF who did not receive NIVH.

Highlights

  • The group treated with NIVH had a 50% decrease in all-cause mortality during the study period
  • The group treated with NIVH had a 28% decline in the risk of hospitalizations
  • The group treated with NIVH had a 52% reduction in the risk of an emergency room visit

Services available to Commonwealth patients will now include:

  • 24/7 on-call support from COPD-certified Respiratory Therapists
  • Remote Physiological Monitoring and Patient Engagement technologies
  • In-home, personalized assessments, equipment setups, care plans, and education
  • Integrated Chronic Care Management
  • Transitional care and compliance programs to optimize adherence and reduce readmissions

Commonwealth’s physicians and patients will also benefit from sleep testing administered in the patient’s home offered through Home Sleep Delivered (“HSD”), a VieMed subsidiary. 

“Commonwealth’s alliance with VieMed creates an outstanding opportunity for us to bring exceptional independent physician care to their respiratory patients. VieMed is driving change in our organization with proven results and I’m excited to see the difference they can make with our patients in Arizona,” said Lance Donkerbrook, CEO of Commonwealth.

VieMed’s CEO, Casey Hoyt, believes the alliance between VieMed and Commonwealth can have a real impact in Arizona, “Commonwealth ACO has done a tremendous job providing their member physicians the proper balance between quality healthcare and cost. I’m excited to see the value VieMed can add to their network and the impact our proven care-continuum can have on their patients.”

VieMed is a home medical equipment supplier that provides post-acute respiratory care services in the United States. Sleep Management, L.L.C. focuses on disease management and improving the quality of life for respiratory patients.

Commonwealth operates as a federally chartered ACO serving the state of Arizona.

VieMed Heathcare Inc. (VMD) is up 3.33 per cent, trading at C$13.05 per share at 10 am EST.

More From The Market Online

Telo Genomics and Emery Pharma collaborate

Telo Genomics (TSXV:TELO) collaborates with Emery Pharma to enhance cellular and molecular bioanalytical solutions for clinical research.

UniDoc brings AI to ER patients

UniDoc (CSE:UDOC) expands its AI partnership with DocBox, further integrating predictive analytics into emergency room operations.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.